
Earnings Summary on United Therapeutics
United Therapeutics (UTHR -5.25%), a biotechnology company focused on therapies for rare and serious conditions such as pulmonary arterial hypertension, released its second-quarter results on July 30, 2025. The company posted record GAAP revenue and …